Severe strongyloidiasis: a systematic review of case reports

BMC Infectious Diseases

Zeno Bisoffi²  Jef Van Den Ende¹  Federico Gobbi²  Jose Muñoz³  Andrea Angheben²  Ana Requena-Mendez³  Dora Buonfrate² 

[1]Department of Clinical sciences, Institute of Tropical Medicine, Antwerp, Belgium

[2]Centre for Tropical Diseases (CTD), Sacro Cuore Hospital, Negrar, Verona, Italy

[3]Barcelona Centre for International Health Research (CRESIB) Hospital Clinic, Barcelona, Spain

关键词: Review;    Disseminated strongyloidiasis;    Hyperinfection;    Strongyloides;    Strongyloidiasis;   

Others  :  1158420
DOI  :  10.1186/1471-2334-13-78

 received in 2012-05-29, accepted in 2013-01-19,  发布年份 2013

【 摘 要 】

Background

Strongyloidiasis is commonly a clinically unapparent, chronic infection, but immuno suppressed subjects can develop fatal disease. We carried out a review of literature on hyperinfection syndrome (HS) and disseminated strongyloidiasis (DS), in order to describe the most challenging aspects of severe strongyloidiasis.

Methods

We conducted a structured search using PubMed to collect case reports and short case series on HS/DS published from 1991 to 2011. We restricted search to papers in English, Spanish, Italian and French. Case reports were classified as HS/DS according to given definitions.

Results

Records screened were 821, and 311 were excluded through titles and abstract evaluation. Of 510 full-text articles assessed for eligibility, 213 were included in qualitative analysis. As some of them were short case series, eventually the number of cases analyzed was 244.

Steroids represented the main trigger predisposing to HS and DS (67% cases): they were mostly administered to treat underlying conditions (e.g. lymphomas, rheumatic diseases). However, sometimes steroids were empirically prescribed to treat signs and symptoms caused by unsuspected/unrecognized strongyloidiasis. Diagnosis was obtained by microscopy examination in 100% cases, while serology was done in a few cases (6.5%). Only in 3/29 cases of solid organ/bone marrow transplantation there is mention of pre-transplant serological screening. Therapeutic regimens were different in terms of drugs selection and combination, administration route and duration. Similar fatality rate was observed between patients with DS (68.5%) and HS (60%).

Conclusions

Proper screening (which must include serology) is mandatory in high - risk patients, for instance candidates to immunosuppressive medications, currently or previously living in endemic countries. In some cases, presumptive treatment might be justified. Ivermectin is the gold standard for treatment, although the optimal dosage is not clearly defined in case of HS/DS.

【 授权许可】

   
2013 Buonfrate et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]WHO: Strongyloidiasis. http://www.who.int/neglected_diseases/diseases/strongyloidiasis/en/ webcite
• [2]Olsen A, Van Lieshout L, Marti H, Polderman T, Polman K, Steinmann P, Stothard R, Thybo S, Verweij JJ, Magnussen P: Strongyloidiasis–the most neglected of the neglected tropical diseases? Trans R Soc Trop Med Hyg 2009, 103(10):967-972.
• [3]Marcos LA, Terashima A, Canales M, Gotuzzo E: Update on Strongyloidiasis in the immunocompromised host. Curr Infect Dis Rep 2011, 13:35-46.
• [4]Boulware DR, Stauffer WM, Hendel-Paterson BR, Rocha JL, Seet RC, Summer AP, Nield LS, Supparatpinyo K, Chaiwarith R, Walker PF: Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey. Am J Med 2007, 120(6):545. e541-548
• [5]Keiser PB, Nutman TB: Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004, 17(1):208-217.
• [6]Agrawal V, Agarwal T, Ghoshal UC: Intestinal strongyloidiasis: a diagnosis frequently missed in the tropics. Trans R Soc Trop Med Hyg 2009, 103(3):242-246.
• [7]Ghosh K: Strongyloides stercoralis septicaemia following steroid therapy for eosinophilia: report of three cases. T Roy Soc Trop Med H 2007, 101(11):1163-1165.
• [8]Das P, Raghu P, Amit Kumar D, Garg P: Strongyloides hyperinfection in rheumatoid arthritis. Int J Surg Pathol 2007, 15(4):391-392.
• [9]Ghoshal UC, Saha J, Ghoshal U, Ray BK, Santra A, Naik S, Mazumder DN: Pigmented nails and Strongyloides stercoralis infestation causing clinical worsening in a patient treated for immunoproliferative small intestinal disease: two unusual observations. J Diarrhoeal Dis Res 1999, 17(1):43-45.
• [10]Ghoshal UC, Ghoshal U, Jain M, Kumar A, Aggarwal R, Misra A, Ayyagari A, Naik SR: Strongyloides stercoralis infestation associated with septicemia due to intestinal transmural migration of bacteria. J Gastroenterol Hepatol 2002, 17(12):1331-1333.
• [11]Ghoshal UC, Alexender G, Ghoshal U, Tripathi S, Krishnani N: Strongyloides stercoralis infestation in a patient with severe ulcerative colitis. Indian J Med Sci 2006, 60(3):106-110.
• [12]Jeyamani R, Joseph AJ, Chacko A: Severe and treatment resistant strongyloidiasis–indicator of HTLV-I infection. Trop Gastroenterol 2007, 28(4):176-177.
• [13]Murali A, Rajendiran G, Ranganathan K, Shanthakumari S: Disseminated infection with Strongyloides stercoralis in a diabetic patient. Indian J Med Microbiol 2010, 28(4):407-408.
• [14]Patil PL, Salkar HR, Ghodeswar SS, Gawande JP: Parasites (filaria & strongyloides) in malignant pleural effusion. Indian J Med Sci 2005, 59(10):455-456.
• [15]Premanand R, Prasad GV, Mohan A, Gururajkumar A, Reddy MK: Eosinophilic pleural effusion and presence of filariform larva of Strongyloides stercoralis in a patient with metastatic squamous cell carcinoma deposits in the pleura. Indian J Chest Dis Allied Sci 2003, 45(2):121-124.
• [16]Rajapurkar M, Hegde U, Rokhade M, Gang S, Gohel K: Respiratory hyperinfection with Strongyloides stercoralis in a patient with renal failure. Nat Clin Pract Nephrol 2007, 3(10):573-577.
• [17]Reddy IS, Swarnalata G: Fatal disseminated strongyloidiasis in patients on immunosuppressive therapy: report of two cases. Indian J Dermatol Venereol Leprol 2005, 71(1):38-40.
• [18]Sathe PA, Madiwale CV: Strongyloidiasis hyperinfection in a patient with membranoproliferative glomerulonephritis. J Postgrad Med 2006, 52(3):221-222.
• [19]Satyanarayana S, Nema S, Kalghatgi AT, Mehta SR, Rai R, Duggal R, Bhardwaj JR: Disseminated Strongyloides stercoralis in AIDS: a report from India. Indian J Pathol Microbiol 2005, 48(4):472-474.
• [20]Sekhar U, Madan M, Ranjitham M, Abraham G, Eapen G: Strongyloides hyperinfection syndrome–an unappreciated opportunistic infection. J Assoc Physicians India 2000, 48(10):1017-1019.
• [21]Soman R, Vaideeswar P, Shah H, Almeida AF: A 34-year-old renal transplant recipient with high-grade fever and progressive shortness of breath. J Postgrad Med 2002, 48(3):191-196.
• [22]Sreenivas DV, Kumar A, Kumar YR, Bharavi C, Sundaram C, Gayathri K: Intestinal strongyloidiasis–a rare opportunistic infection. Indian J Gastroenterol: J Indian Soc Gastroenterol 1997, 16(3):105-106.
• [23]Vigg A, Mantri S, Reddy VA, Biyani V: Acute respiratory distress syndrome due to Strongyloides stercoralis in non-Hodgkin’s lymphoma. Indian J Chest Dis Allied Sci 2006, 48(1):67-69.
• [24]Bava AJ, Troncoso AR: Strongyloides stercoralis hyperinfection in a patient with AIDS. J Int Assoc Physicians AIDS Care (Chic) 2009, 8(4):235-238.
• [25]Galimberti R, Ponton A, Zaputovich FA, Velasquez L, Galimberti G, Torre A, Kowalczuk A: Disseminated strongyloidiasis in immunocompromised patients–report of three cases. Int J Dermatol 2009, 48(9):975-978.
• [26]Rivero FD, Kremer LE, Allende L, Casero RD: [Strongyloides stercoralis and HIV: a case report of an indigenous disseminated infection from non-endemic area]. Rev Argent Microbiol 2006, 38(3):137-139.
• [27]Taranto NJ: [Strongyloides stercoralis. Report of a case and review of the literature]. Acta Gastroenterol Latinoam 1995, 25(2):113-120.
• [28]Trione N, Corti M, Castello T, Abuin JC, Bellegarde E: [Disseminated infection due to strongyloides stercoralis in AIDS patients. A report of 2 cases]. Acta Gastroenterol Latinoam 2001, 31(5):399-402.
• [29]Dulley FL, Costa S, Cosentino R, Gamba C, Saboya R: Strongyloides stercoralis hyperinfection after allogeneic stem cell transplantation. Bone Marrow Transplant 2009, 43(9):741-742.
• [30]Salluh JI, Feres GA, Velasco E, Holanda GS, Toscano L, Soares M: Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock. Intensive Care Med 2005, 31(9):1292.
• [31]German JC, Flores JH, Chiesura G, Ruiz EM, Flores SS, Laudanna AA: [Fatal strongyloidiasis in an immunodepressed patient following renal transplantation]. Revista do Hospital das Clinicas 1992, 47(1):31-33.
• [32]Lambertucci JR, Leao FC, Barbosa AJ: Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1). Rev Soc Bras Med Trop 2003, 36(4):541-542.
• [33]Lambertucci JR, Westin MR, Barbosa AJ: Severe gastrointestinal strongyloidiasis. Rev Soc Bras Med Trop 2005, 38(4):365-366.
• [34]Rodrigues MA, Froes RC, Anefalos A, Kobayasi S: Invasive enteritis by Strongyloides stercoralis presenting as acute abdominal distress under corticosteroid therapy. Revista do Hospital das Clinicas 2001, 56(4):103-106.
• [35]Porto MA, Alcantara LM, Leal M, Castro N, Carvalho EM: Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I. Am J Trop Med H 2005, 72(2):124-125.
• [36]Siciliano RF, Mascheretti M, Ho YL, Gryschek RC: Severe strongyloidiasis in AIDS: is steroid therapy guilty again? J Acquir Immune Defic Syndr 2008, 49(3):333-334.
• [37]Tabacof J, Feher O, Katz A, Simon SD, Gansl RC: Strongyloides hyperinfection in two patients with lymphoma, purulent meningitis, and sepsis. Cancer 1991, 68(8):1821-1823.
• [38]Takayanagui OM, Lofrano MM, Araugo MB, Chimelli L: Detection of Strongyloides stercoralis in the cerebrospinal fluid of a patient with acquired immunodeficiency syndrome. Neurology 1995, 45(1):193-194.
• [39]Vilela EG, Clemente WT, Mira RR, Torres HO, Veloso LF, Fonseca LP, De Carvalho EFLR, Franca MC, Lima AS: Strongyloides stercoralis hyperinfection syndrome after liver transplantation: case report and literature review. Transplant Inf Dis: J Transplant Soc 2009, 11(2):132-136.
• [40]De Goede E, Martens M, Van Rooy S, VanMoerkerke I: A case of systemic strongyloidiasis in an ex-coal miner with idiopathic colitis. European J Gastroenterol Hepatol 1995, 7(8):807-809.
• [41]Mora CS, Segami MI, Hidalgo JA: Strongyloides stercoralis hyperinfection in systemic lupus erythematosus and the antiphospholipid syndrome. Semin Arthritis Rheu 2006, 36(3):135-143.
• [42]Zavala J, Sanchez L, Carillo L, Cueva A, Balbin G, Quispe V: [Atypical presentations of strongyloidiasis: a report of 8 cases]. Rev Gastroenterol Peru 1994, 14(1):15-21.
• [43]Adetiloye VA: A case of fatal gastrointestinal strongyloidiasis in an otherwise healthy Nigerian, masquerading as gastric outlet obstruction. Trop Geogr Med 1992, 44(1–2):60-62.
• [44]Coovadia YM, Rajput MC, Bhana RH: Disseminated strongyloidiasis in a diabetic patient. Trop Geogr Med 1993, 45(4):179-180.
• [45]Daubenton JD, Buys HA, Hartley PS: Disseminated strongyloidiasis in a child with lymphoblastic lymphoma. J Pediatr Hematol Oncol: Am Soc Pediatr Hematol Oncol 1998, 20(3):260-263.
• [46]Haddow LJ, Mahlakwane MS, Ramdial PK, Moosa MY: Histopathology of Strongyloides stercoralis hyperinfection during immune reconstitution in an HIV-infected patient. AIDS 2009, 23(12):1609-1611.
• [47]Jamil SA, Hilton E: The Strongyloides hyperinfection syndrome. New York State J 1992, 92(2):67-68.
• [48]Purvis RS, Beightler EL, Diven DG, Sanchez RL, Tyring SK: Strongyloides hyperinfection presenting with petechiae and purpura. Nt J Dermatol 1992, 31(3):169-171.
• [49]Boken DJ, Leoni PA, Preheim LC: Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum. Clin Infect Dis: Infect Dis Soc Am 1993, 16(1):123-126.
• [50]Celedon JC, Mathur-Wagh U, Fox J, Garcia R, Wiest PM: Systemic strongyloidiasis in patients infected with the human immunodeficiency virus. A report of 3 cases and review of the literature. Medicine 1994, 73(5):256-263.
• [51]El Masry HZ, O’Donnell J: Fatal stongyloides hyperinfection in heart transplantation. J Heart Lung Transpl: Int Soc Heart Transpl 2005, 24(11):1980-1983.
• [52]Foreman EB, Abraham PJ, Garland JL: Not your typical strongyloides infection: a literature review and case study. South Med J 2006, 99(8):847-852.
• [53]Friedenberg F, Wongpraparut N, Fischer RA, Gubernick J, Zaeri N, Eiger G, Ozden Z: Duodenal obstruction caused by Strongyloides stercoralis enteritis in an HTLV-1-infected host. Digest Dis Sci 1999, 44(6):1184-1188.
• [54]Fusco DN, Downs JA, Satlin MJ, Pahuja M, Ramos L, Barie PS, Fleckenstein L, Murray HW: Non-oral treatment with ivermectin for disseminated strongyloidiasis. Am J Trop Med Hyg 2010, 83(4):879-883.
• [55]Nomura J, Rekrut K: Strongyloides stercoralis hyperinfection syndrome in a patient with AIDS: diagnosis by fluorescent microscopy. Clin inf dis: Inf Dis Soc Am 1996, 22(4):736.
• [56]Goldman DE, Grier JF, Ball BE, Abreo F, Abreo KD: A 72-year-old woman with non-Hodgkin’s lymphoma, dyspnea, vomiting, diarrhea, and eosinophilia. J La State Med Soc: Louisiana State Med Soc 1995, 147(6):243-250.
• [57]Gordon SM, Gal AA, Solomon AR, Bryan JA: Disseminated strongyloidiasis with cutaneous manifestations in an immunocompromised host. J Am Acad Dermatol 1994, 31(2 Pt 1):255-259.
• [58]Gulick RM: Reappearance of a remotely acquired infection. AIDS Clin Care 1997, 9(9):70.
• [59]Gutierrez Y, Bhatia P, Garbadawala ST, Dobson JR, Wallace TM, Carey TE: Strongyloides stercoralis eosinophilic granulomatous enterocolitis. Am J Surg Pathol 1996, 20(5):603-612.
• [60]Hamilton KW, Abt PL, Rosenbach MA, Bleicher MB, Levine MS, Mehta J, Montgomery SP, Hasz RD, Bono BR, Tetzlaff MT, et al.: Donor-derived Strongyloides stercoralis infections in renal transplant recipients. Transplantation 2011, 91(9):1019-1024.
• [61]Hong IS, Zaidi SY, McEvoy P, Neafie RC: Diagnosis of Strongyloides stercoralis in a peritoneal effusion from an HIV-seropositive man. A case report. Acta Cytol 2004, 48(2):211-214.
• [62]Jain AK, Agarwal SK, El-Sadr W: Streptococcus bovis bacteremia and meningitis associated with Strongyloides stercoralis colitis in a patient infected with human immunodeficiency virus. Cli inf dis: Inf Dis Soc Am 1994, 18(2):253-254.
• [63]Kao D, Murakawa GJ, Kerschmann R, Berger T: Disseminated strongyloidiasis in a patient with acquired immunodeficiency syndrome. Arch Dermatol 1996, 132(8):977-978.
• [64]Kothary NN, Muskie JM, Mathur SC: Strongyloides stercoralis hyperinfection. Radiographics: Radiological SocNorth Am Inc 1999, 19(4):1077-1081.
• [65]Lambroza A, Dannenberg AJ: Eosinophilic ascites due to hyperinfection with Strongyloides stercoralis. Am J Gastroenterol 1991, 86(1):89-91.
• [66]Lemos LB, Qu Z, Laucirica R, Fred HL: Hyperinfection syndrome in strongyloidiasis: report of two cases. Ann Diagn Pathol 2003, 7(2):87-94.
• [67]Lin AL, Kessimian N, Benditt JO: Restrictive pulmonary disease due to interlobular septal fibrosis associated with disseminated infection by Strongyloides stercoralis. Am J Respir Crit Care Med 1995, 151(1):205-209.
• [68]Link K, Orenstein R: Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis. South Med J 1999, 92(7):728-731.
• [69]Malhotra A, Kochar T, Rangasetty UC: A perfect host. Intern Med J 2008, 38(11):869-870.
• [70]Schaeffer MW, Buell JF, Gupta M, Conway GD, Akhter SA, Wagoner LE: Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature. J Heart Lung Transpl: Int Soc Heart Transpl 2004, 23(7):905-911.
• [71]Tarr PE, Miele PS, Peregoy KS, Smith MA, Neva FA, Lucey DR: Case report: Rectal adminstration of ivermectin to a patient with Strongyloides hyperinfection syndrome. Am J Trop Med Hyg 2003, 68(4):453-455.
• [72]Marty FM, Lowry CM, Rodriguez M, Milner DA, Pieciak WS, Sinha A, Fleckenstein L, Baden LR: Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Inf Dis: Inf Dis Soc Am 2005, 41(1):e5-e8.
• [73]Miller MA, Church LW, Salgado CD: Strongyloides hyperinfection: a treatment dilemma. Am J Med Sci 2008, 336(4):358-361.
• [74]Mizuno S, Iida T, Zendejas I, Martin TD, Schain DC, Turner B, Fujita S: Strongyloides hyperinfection syndrome following simultaneous heart and kidney transplantation. Transplant Int: J European Soc Organ Transplant 2009, 22(2):251-253.
• [75]Morgello S, Soifer FM, Lin CS, Wolfe DE: Central nervous system Strongyloides stercoralis in acquired immunodeficiency syndrome: a report of two cases and review of the literature. Acta Neuropathol 1993, 86(3):285-288.
• [76]Morrell MR, Dallas J, Kollef MH: A 50-year-old woman with abdominal pain and respiratory failure 3 months after kidney transplantation. Chest 2008, 134(2):442-446.
• [77]Newton RC, Limpuangthip P, Greenberg S, Gam A, Neva FA: Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression. Am J Med 1992, 92(2):202-208.
• [78]Gupta S, Jain A, Fanning TV, Couriel DR, Jimenez CA, Eapen GA: An unusual cause of alveolar hemorrhage post hematopoietic stem cell transplantation: a case report. BMC Cancer 2006, 6:87. BioMed Central Full Text
• [79]Perazella MA, Sadigh M: Acute nonspecific illness in an AIDS patients with dysphagia. Hosp Pract (Off Ed) 1994, 29(11):39. 43, 47
• [80]Phelps KR, Ginsberg SS, Cunningham AW, Tschachler E, Dosik H: Case report: adult T-cell leukemia/lymphoma associated with recurrent strongyloides hyperinfection. Am J Med Sci 1991, 302(4):224-228.
• [81]Qazilbash MH, Ueno NT, Hosing C, De Lima M, Cortes J, Massaro A, Rivera Z, Deavers M, Adachi JA, Champlin RE: Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 2006, 38(5):393-394.
• [82]Purvis RS, Beightler EL, Diven DG, Sanchez RL, Tyring SK: Strongyloides stercoralis hyperinfection. Int J Dermatol 1992, 31(3):160-164.
• [83]Krishnamurthy R, Dincer HE, Whittemore D: Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy. J Clin Rheumatology: Rheumatic & musculoskeletal dis 2007, 13(3):150-152.
• [84]Reddy TS, Myers JW: Syndrome of inappropriate secretion of antidiuretic hormone and nonpalpable purpura in a woman with Strongyloides stercoralis hyperinfection. Am Journal Med Sci 2003, 325(5):288-291.
• [85]Gorman SR, Craven DE: Images in clinical medicine. Strongyloides stercoralis hyperinfection. New England J Med 2008, 359(11):e12.
• [86]Reiman S, Fisher R, Dodds C, Trinh C, Laucirica R, Whigham CJ: Mesenteric arteriographic findings in a patient with strongyloides stercoralis hyperinfection. JVIR 2002, 13(6):635-638.
• [87]Roxby AC, Gottlieb GS, Limaye AP: Strongyloidiasis in transplant patients. Clin Inf Dis: Inf Dis So Am 2009, 49(9):1411-1423.
• [88]Patel G, Arvelakis A, Sauter BV, Gondolesi GE, Caplivski D, Huprikar S: Strongyloides hyperinfection syndrome after intestinal transplantation. Transpl inf Dis: J Transplant Soc 2008, 10(2):137-141.
• [89]Schindzielorz A, Edberg SC, Bia FJ: Strongyloides stercoralis hyperinfection and central nervous system involvement in a patient with relapsing polychondritis. Southern Med J 1991, 84(8):1055-1057.
• [90]Lichtenberger P, Rosa-Cunha I, Morris M, Nishida S, Akpinar E, Gaitan J, Tzakis A, Doblecki-Lewis S: Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin. Transplant Inf Disease: J Transplant SocS 2009, 11(2):137-142.
• [91]Agarwal VK, Khurana HS, Le HX, Mathisen G, Kamangar N: 30-year-old HIV-positive female with diffuse alveolar hemorrhage. J Int Care Med 2009, 24(3):200-204.
• [92]Balagopal A, Mills L, Shah A, Subramanian A: Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation. Transplant Inf Dis: J Transplant Soc 2009, 11(2):149-154.
• [93]Simpson WG, Gerhardstein DC, Thompson JR: Disseminated Strongyloides stercoralis infection. Southern Med J 1993, 86(7):821-825.
• [94]Huston JM, Eachempati SR, Rodney JR, Cayci C, Fusco D, Mathew M, Shou J, Goldstein MJ, Kapur S, Barie PS: Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient. Transplant Inf Dis: J Transplant Soc 2009, 11(3):277-280.
• [95]Khasawneh F, Sreedhar R, Chundi V: Strongyloides hyperinfection: an unusual cause of respiratory failure. Ann Intern Med 2009, 150(8):570-571.
• [96]Thompson JR, Berger R: Fatal adult respiratory distress syndrome following successful treatment of pulmonary strongyloidiasis. Chest 1991, 99(3):772-774.
• [97]Aregawi D, Lopez D, Wick M, Scheld WM, Schiff D: Disseminated strongyloidiasis complicating glioblastoma therapy: a case report. J Neurooncol 2009, 94(3):439-443.
• [98]Apewokin S, Steciuk M, Griffin S, Jhala D: Strongyloides hyperinfection diagnosed by bronchoalveolar lavage in an immunocompromized host. Cytopathology: Journal of the British Soc Clin Cytol 2010, 21(5):345-347.
• [99]Upadhyay D, Corbridge T, Jain M, Shah R: Pulmonary hyperinfection syndrome with Strongyloides stercoralis. Am J Med 2001, 111(2):167-169.
• [100]Basile A, Simzar S, Bentow J, Antelo F, Shitabata P, Peng SK, Craft N: Disseminated Strongyloides stercoralis: hyperinfection during medical immunosuppression. J Am Acad Dermatol 2010, 63(5):896-902.
• [101]Vadlamudi RS, Van Dort M, Barklow T, Byrd RP Jr, Moorman JP: Strongyloides hyperinfection syndrome complicating (ectopic) Cushing syndrome. Southern Med J 2008, 101(7):750-752.
• [102]Wang BY, Krishnan S, Isenberg HD: Mortality associated with concurrent strongyloidosis and cytomegalovirus infection in a patient on steroid therapy. Mount Sinai J Med New York 1999, 66(2):128-132.
• [103]Williams BT, Guerry-Force ML: Disseminated strongyloidiasis in a World War II Veteran with metastatic undifferentiated carcinoma of neuroendocrine type. Southern Med J 1992, 85(10):1023-1026.
• [104]Wirk B, Wingard JR: Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation. Transplant Inf Dis: J Transplant Soc 2009, 11(2):143-148.
• [105]Grein JD, Mathisen GE, Donovan S, Fleckenstein L: Serum ivermectin levels after enteral and subcutaneous administration for Strongyloides hyperinfection: a case report. Scandinavian J Inf Dis 2010, 42(3):234-236.
• [106]Martin SJ, Cohen PR, MacFarlane DF, Grossman ME: Cutaneous manifestations of Strongyloides stercoralis hyperinfection in an HIV-seropositive patient. Skinmed 2011, 9(3):199-202.
• [107]Weiser JA, Scully BE, Bulman WA, Husain S, Grossman ME: Periumbilical parasitic thumbprint purpura: strongyloides hyperinfection syndrome acquired from a cadaveric renal transplant. Transplant Inf Dis: J Transplant Soc 2011, 13(1):58-62.
• [108]Lessnau KD, Can S, Talavera W: Disseminated Strongyloides stercoralis in human immunodeficiency virus-infected patients. Treatment failure and a review of the literature. Chest 1993, 104(1):119-122.
• [109]Ali HA, Walkenstein M: Bilateral nodular pulmonary infiltrates in an immunocompromised host. Thorax 2008, 63(8):746-753.
• [110]Hughes R, McGuire G: Delayed diagnosis of disseminated strongyloidiasis. Intensive Care Med 2001, 27(1):310-312.
• [111]Lagace-Wiens PR, Harding GK: A Canadian immigrant with coinfection of Strongyloides stercoralis and human T-lymphotropic virus 1. CMAJ 2007, 177(5):451-453.
• [112]Leung V, Al-Rawahi GN, Grant J, Fleckenstein L, Bowie W: Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection. Am J Trop Med Hyg 2008, 79(6):853-855.
• [113]Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC: Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ 2004, 171(5):479-484.
• [114]Peters L, McCarthy AE, Faught C: Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases. IJID: Int Soc Inf Dis 2009, 13(6):e501-e503.
• [115]Rawat B, Simons ME: Strongyloides stercoralis hyperinfestation. Another cause of focal hepatic lesions. Clin Imaging 1993, 17(4):274-275.
• [116]Turner SA, Maclean JD, Fleckenstein L, Greenaway C: Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis. Am J Trop Med Hyg 2005, 73(5):911-914.
• [117]Vandebosch S, Mana F, Goossens A, Urbain D: Strongyloides Stercoralis infection associated with repititive bacterial meningitis and SIADH: a case report. Acta gastro-enterologica Belgica 2008, 71(4):413-417.
• [118]Collet F, Favory R, Augusto D, Moukassa D, Dutoit E, Mathieu D: [Massive haemoptysis associated with pulmonary Strongyloides stercoralis hyperinfestation]. Rev Mal Respir 2005, 22(5 Pt 1):815-818.
• [119]Couprie R, Maslo C, Bouchaud O, Matheron S, Saimot AG, Coulaud JP: [Disseminated anguilluliasis in HIV infection. A new case]. Presse Med 1993, 22(20):968.
• [120]Daoudal P, Ribier G, Numeric P, Desbois N, Ramialison C: [Disseminated strongyloidiasis, a rare cause of multiple organ failure]. Presse Med 2002, 31(26):1216-1217.
• [121]Gloro R, Ollivier-Hourmand I, Morin-Fatome A, Rousselot P, Le Moel G, Dao T: [Disseminated strongyloidiasis associated with pulmonary fibrosis and gastrointestinal bleeding]. Gastroenterol Clin Biol 2004, 28(12):1287-1290.
• [122]Hovette P, Tuan JF, Camara P, Lejean Y, Lo N, Colbacchini P: [Pulmonary strongyloidiasis complicated by E. coli meningitis in a HIV-1 and HTLV-1 positive patient]. Presse Med 2002, 31(22):1021-1023.
• [123]Marsan C, Marais MH, Sollet JP, Le Turdu F, Guerin PH, Garcia R, Bleichner G: Disseminated strongyloidiasis: a case report. Cytopathology: J British Soc Clin Cytol 1993, 4(2):123-126.
• [124]Mattioni S, Valin N, Cracco C, Thellier M, Danis M, Caumes E: Fatal relapse of disseminated strongyloidiasis in an HIV-positive patient, despite ivermectin treatment. Ann Trop Med Parasitol 2008, 102(8):693-698.
• [125]Mejia JH, Denis M, Leleu G, Roux P, Mayaud C, Akoun G: [Acute respiratory insufficiency caused by hyperinfestation with strongyloides. BALF diagnosis and favourable outcome]. Rev Pneumol Clin 1992, 48(2):75-78.
• [126]Pacanowski J, Santos MD, Roux A, LEM C, Guillot J, Lavarde V, Cornet M: Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Am J Trop Med Hyg 2005, 73(1):122-124.
• [127]Pinatelle P, De Monbrison F, Bedock B: [Disseminated strongyloidiasis with parasitemia in a patient under corticosteroid-treatment]. Med Mal Infect 2009, 39(4):267-269.
• [128]Quinio D, Moalic E, Masure O, Renault A, Le Flohic AM: [Pulmonary manifestations of malignant strongyloidiasis]. Rev Mal Respir 2002, 19(2 Pt1):265-266.
• [129]Said S, Nevez G, Moriniere P, Fournier A, Raccurt CP: [Hemodialysis and strongyloidiasis: a presumed cause of eosinophilia able to mask the other]. Nephrologie 1999, 20(6):343-346.
• [130]Hauber HP, Galle J, Chiodini PL, Rupp J, Birke R, Vollmer E, Zabel P, Lange C: Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin. Infection 2005, 33(5–6):383-386.
• [131]Steiner B, Riebold D, Wolff D, Freund M, Reisinger EC: Strongyloides stercoralis eggs in a urethral smear after bone marrow transplantation. Clin Inf Dis: Inf Dis Soc Am 2002, 34(9):1280-1281.
• [132]Almasidou D, Maniatis M, Vassiou K, Damani E, Vakalis N, Fesoulidis I, Gourgoulianis KI: Strongyloides hyperinfection in a patient with sarcoidosis. Respirology 2003, 8(1):105-106.
• [133]Bamias G, Toskas A, Psychogiou M, Delladetsima I, Siakavellas SI, Dimarogona K, Daikos GL: Strongyloides hyperinfection syndrome presenting as enterococcal meningitis in a low-endemicity area. Virulence 2010, 1(5):468-470.
• [134]Kosmadakis G, Georgoulias C, Filiopoulos V, Stefanou I, Smirloglou D, Michail S: Lethal Strongyloides stercoralis superinfection in an immunocompromised patient. Ren Fail 2010, 32(6):750-752.
• [135]Casati A, Cornero G, Muttini S, Tresoldi M, Gallioli G, Torri G: Hyperacute pneumonitis in a patient with overwhelming Strongyloides stercoralis infection. Eur J Anaesthesiol 1996, 13(5):498-501.
• [136]Gulletta M, Chatel G, Pavia M, Signorini L, Tebaldi A, Bombana E, Carosi G: AIDS and strongyloidiasis. Int J STD AIDS 1998, 9(7):427-429.
• [137]Mariotta S, Pallone G, Li Bianchi E, Gilardi G, Bisetti A: Strongyloides stercoralis hyperinfection in a case of idiopathic pulmonary fibrosis. Panminerva Med 1996, 38(1):45-47.
• [138]Pampiglione S, Pampiglione E, Di Stefano MA: [Strongyloides stercoralis hyperinfection with encephalitis manifestations]. Pathologica 1993, 85(1096):195-204.
• [139]Rotolo U, Scarlata F, Giordano S, Tortorici C, Bono L, Coglitore M, Faraci C, Infurnari L, Rubino R, Romano A: [Nephrotic syndrome and Gram-negative sepsis in a patient with strongyloidiasis: a case report]. Le infezioni in medicina: rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 2007, 15(1):59-62.
• [140]Sidoni A, Polidori GA, Alberti PF, Scionti L: Fatal Strongyloides stercoralis hyperinfection diagnosed by Papanicolaou-stained sputum smears. Pathologica 1994, 86(1):87-90.
• [141]Lanzafame M, Faggian F, Lattuada E, Antolini D, Vento S: Strongyloidiasis in an HIV-1-infected patient after highly active antiretroviral therapy-induced immune restoration. J Infect Dis 2005, 191(6):1027.
• [142]Brugemann J, Kampinga GA, Riezebos-Brilman A, Stek CJ, Edel JP, van der Bij W, Sprenger HG, Zijlstra F: Two donor-related infections in a heart transplant recipient: one common, the other a tropical surprise. J Heart Lung Transplant: Int Soc Heart Transplant 2010, 29(12):1433-1437.
• [143]Grijsen M, van den Berk G, Hoekstra E, Terpstra W, Veldman S, Jansen J: Intestinal strongyloidiasis as a presenting symptom of HTLV-1-associated adult T-cell leukemia/lymphoma. Endoscopy 2009, 41(Suppl 2):E271-E272.
• [144]Janssen R, Vlaminckx BJ, Seldenrijk CA, Voorn GP, Grutters JC: Strongyloides stercoralis hyperinfection mimicking accelerated form of idiopathic pulmonary fibrosis. Lancet Inf Dis 2008, 8(7):456.
• [145]Van Hattem S, Schuttelaar ML: Disseminated strongyloidiasis caused by heart donor-to-host transmission presenting with purpura. Clin Exp Dermatol 2010, 35(4):e149-e150.
• [146]Gomez J, Plaza V, Munoz C, Franquet T: [Hyperinfection by Strongyloides stercoralis and other pathogens in a patient with chronic obstructive airways disease]. Medicina clinica 1997, 109(15):609.
• [147]Llagunes J, Mateo E, Pena JJ, Carmona P, De Andres J: [Hyperinfection caused by Strongyloides stercoralis]. Medicina intensiva/Sociedad Espanola de Medicina Intensiva y Unidades Coronarias 2010, 34(5):353-356.
• [148]Lopez Gallardo A, Diez Garcia F, Yelamos F, Orozco F: [Hyperinfection by Strongyloides stercoralis in a patient with ulcerative colitis]. Enferm Infecc Microbiol Clin 1997, 15(5):273.
• [149]Mayayo E, Gomez-Aracil V, Azua-Blanco J, Azua-Romeo J, Capilla J, Mayayo R: Strongyloides stercolaris infection mimicking a malignant tumour in a non-immunocompromised patient. Diagnosis by bronchoalveolar cytology. J Clin Pathol 2005, 58(4):420-422.
• [150]Rodriguez-Hernandez MJ, Ruiz-Perez-Pipaon M, Canas E, Bernal C, Gavilan F: Strongyloides stercoralis hyperinfection transmitted by liver allograft in a transplant recipient. Am J Transplant: J Am Soc Transplant Am Soc Transplant Sur 2009, 9(11):2637-2640.
• [151]Rojo-Marcos G, Cuadros-Gonzalez J, Gonzalez-Juarez MJ, Gomez-Ayerbe C: [Strongyloides stercoralis hyperinfection syndrome in a Colombian patient receiving immunosuppressive treatment]. Enferm Infecc Microbiol Clin 2009, 27(7):432-434.
• [152]Sauca Subias G, Barrufet Barque P, Besa Beringues A, Rodriguez Ramos E: [Strongyloides stercoralis hyperinfection in a patient with acquired immunodeficiency syndrome]. An Med Interna 2005, 22(3):139-141.
• [153]Tirado MD, Gil M, Galiano J, Pardo F, Moreno R, Del Busto AG, Sabater S, Gomila B: [Respiratory and renal insufficiency in a COPD patient receiving corticoid treatment]. Enferm Infecc Microbiol Clin 2002, 20(8):401-402.
• [154]Tornero C, Galan A, Garrigos E, Ramos JA, Pastor A: [Hyperinfection by S. stercoralis: membranous glomerulonephritis, double bacteremia and petechiae exanthema]. Enferm Infecc Microbiol Clin 1998, 16(10):495-496.
• [155]Troncoso Garcia E, Munoz Medina L, Callejas Rubio JL, Lopez Ruz MA: [Klebsiella pneumoniae meningitis, Strongyloides stercoralis infection and HTLV-1]. Medicina clinica 2000, 115(4):158.
• [156]Pusztaszeri M, Bouzourene H: [Intestinal and disseminated strongyloidosis: two case studies]. Ann Pathol 2005, 25(4):322-326.
• [157]Brown M, Cartledge JD, Miller RF: Dissemination of Strongyloides stercoralis as an immune restoration phenomenon in an HIV-1-infected man on antiretroviral therapy. Int J STD AIDS 2006, 17(8):560-561.
• [158]Chiodini PL, Reid AJ, Wiselka MJ, Firmin R, Foweraker J: Parenteral ivermectin in Strongyloides hyperinfection. Lancet 2000, 355(9197):43-44.
• [159]Feely NM, Waghorn DJ, Dexter T, Gallen I, Chiodini P: Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatment. Anaesthesia 2010, 65(3):298-301.
• [160]Gill GV, Beeching NJ, Khoo S, Bailey JW, Partridge S, Blundell JW, Luksza AR: A British Second World War veteran with disseminated strongyloidiasis. T Roy Soc Trop Med H 2004, 98(6):382-386.
• [161]Harcourt-Webster JN, Scaravilli F, Darwish AH: Strongyloides stercoralis hyperinfection in an HIV positive patient. J Clin Pathol 1991, 44(4):346-348.
• [162]Orlent H, Crawley C, Cwynarski K, Dina R, Apperley J: Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2003, 32(1):115-117.
• [163]Pagliuca A: Strongyloides hyperinfection in adult T-cell leukaemia/lymphoma. British J Haematol 1999, 105(1):1.
• [164]Rahim S, Drabu Y, Jarvis K, Melville D: Strongyloidiasis: a mistaken diagnosis and a fatal outcome in a patient with diarrhoea. Trans R Soc Trop Med H 2005, 99(3):215-217.
• [165]Heath T, Riminton S, Garsia R, MacLeod C: Systemic strongyloidiasis complicating HIV: a promising response to ivermectin. Int J STD AIDS 1996, 7(4):294-296.
• [166]Lim L, Biggs BA: Fatal disseminated strongyloidiasis in a previously treated patient. Med J Australia 2001, 174(7):355-356.
• [167]Mak DB: Recurrent bacterial meningitis associated with strongyloides hyperinfection. Med J Australia 1993, 159(5):354.
• [168]Mak DB: Recurrent bacterial meningitis associated with strongyloides hyperinfection. Med J Aust 1993, 159(5):354.
• [169]Thomas MC, Costello SA: Disseminated strongyloidiasis arising from a single dose of dexamethasone before stereotactic radiosurgery. Int J Clin Prac 1998, 52(7):520-521.
• [170]Kanazawa S, Yamaguchi K, Kinoshita Y, Nomura S: Adult T-cell leukaemia and strongyloidiasis. Eur J Cancer Care (Engl) 2008, 17(2):209-210.
• [171]Kinjo T, Tsuhako K, Nakazato I, Ito E, Sato Y, Koyanagi Y, Iwamasa T: Extensive intra-alveolar haemorrhage caused by disseminated strongyloidiasis. Int J Parasitol 1998, 28(2):323-330.
• [172]Miyazaki M, Tamura M, Kabashima N, Serino R, Shibata T, Miyamoto T, Furuno Y, Nishio T, Ohara J, Sakurai T, et al.: Minimal change nephrotic syndrome in a patient with strongyloidiasis. Clin Exp Nephrol 2010, 14(4):367-371.
• [173]Mori S, Konishi T, Matsuoka K, Deguchi M, Ohta M, Mizuno O, Ueno T, Okinaka T, Nishimura Y, Ito N, et al.: Strongyloidiasis associated with nephrotic syndrome. Intern Med 1998, 37(7):606-610.
• [174]Morimoto J, Kaneoka H, Sasatomi Y, Sato YN, Murata T, Ogahara S, Sakata N, Takebayashi S, Naito S, Saito T: Disseminated strongyloidiasis in nephrotic syndrome. Clin Nephrol 2002, 57(5):398-401.
• [175]Satoh M, Futami A, Takahira K, Kodaira M, Tanaka T, Kuriki K, Hori E: Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load. J Infect Chemother 2003, 9(4):355-357.
• [176]Setoyama M, Fukumaru S, Takasaki T, Yoshida H, Kanzaki T: SLE with death from acute massive pulmonary hemorrhage caused by disseminated strongyloidiasis. Scand J Rheumatol 1997, 26(5):389-391.
• [177]Wong VW, Leung WK, To KF, Sung JJ: Diarrhoea and rash in a retired farmer. HKMJ, Xianggang yi xue za zhi/Hong Kong Academy of Medicine 2005, 11(5):397-398.
• [178]Chiu HH, Lai SL: Fatal meningoencephalitis caused by disseminated strongyloidiasis. Acta Neurol Taiwan 2005, 14(1):24-27.
• [179]Hsieh YP, Wen YK, Chen ML: Minimal change nephrotic syndrome in association with strongyloidiasis. Clin Nephrol 2006, 66(6):459-463.
• [180]Huang MS, Hwang KP, Chiang PC, Hwang JJ: Pulmonary hyperinfection with Strongyloides stercoralis. J Formos Med Asso, Taiwan yi zhi 1996, 95(7):551-554.
• [181]Ting YM: Pulmonary strongyloidiasis–case report of 2 cases. Kaohsiung J Med Sci 2000, 16(5):269-274.
• [182]Liu HC, Hsu JY, Chang KM: Strongyloides stercoralis hyperinfection presenting with symptoms mimicking acute exacerbation of chronic obstructive pulmonary disease. JCMA 2009, 72(8):442-445.
• [183]Hira PR, Al-Ali F, Shweiki HM, Abdella NA, Johny M, Francis I, Iqbal J, Thompson R, Nevar F: Strongyloidiasis: challenges in diagnosis and management in non-endemic Kuwait. Ann Trop Med Parasitol 2004, 98(3):261-270.
• [184]Mokaddas EM, Shati S, Abdulla A, Nampoori NR, Iqbal J, Nair PM, Said T, Abdulhalim M, Hira PR: Fatal strongyloidiasis in three kidney recipients in Kuwait. Med Princ Pract: Int J K U, Health Sci Centre 2009, 18(5):414-417.
• [185]Al Maslamani MA, Al Soub HA, Al Khal AL, Al Bozom IA, Abu Khattab MJ, Chacko KC: Strongyloides stercoralis hyperinfection after corticosteroid therapy: a report of two cases. Ann Saudi Med 2009, 29(5):397-401.
• [186]Uwaydah AK, Al Qadah F: Strongyloides stercoralis hyperinfection in a patient with angioimmunoblastic lymphadenopathy. Postgrad Med J 1992, 68(806):974-975.
• [187]Malnick S, Somin M, Beilinson N, Basevitch A, Bregman G, Zimhony O: Strongyloides hyperinfection in Ethiopian immigrants in Israel. IMAJ 2009, 11(11):660-663.
• [188]Somin M, Neogolani V, Zimhony O, Wolpart A, Sokolowski N, Malnick S: Fatal recurrent bacterial meningitis: a complication of chronic Strongyloides infection. Eur J Int Med 2008, 19(6):e42-e43.
• [189]Kia EB, Rahimi HR, Mirhendi H, Nilforoushan MR, Talebi A, Zahabiun F, Kazemzadeh H, Meamar AR: A case of fatal strongyloidiasis in a patient with chronic lymphocytic leukemia and molecular characterization of the isolate. Korean J Parasitol 2008, 46(4):261-263.
• [190]Gulbas Z, Kebapci M, Pasaoglu O, Vardareli E: Successful ivermectin treatment of hepatic strongyloidiasis presenting with severe eosinophilia. South Med J 2004, 97(9):907-910.
• [191]Incani RN, Hernandez M, Cortez J, Gonzalez ME, Salazar YD: Staphylococcus warneri meningitis in a patient with Strongyloides stercoralis hyperinfection and lymphoma: first report of a case. Rev Inst Med Trop Sao Paulo 2010, 52(3):169-170.
• [192]Chaudhary K, Smith RJ, Himelright IM, Baddour LM: Case report: purpura in disseminated strongyloidiasis. Am J Med Sci 1994, 308(3):186-191.
• [193]Davidson RA: Infection due to Strongyloides stercoralis in patients with pulmonary disease. South Med J 1992, 85(1):28-31.
• [194]Kim J, Joo HS, Ko HM, Na MS, Hwang SH, Im JC: A case of fatal hyperinfective strongyloidiasis with discovery of autoinfective filariform larvae in sputum. Korean J Parasitol 2005, 43(2):51-55.
• [195]Ochoa MD, Ramirez-Mendoza P, Ochoa G, Vargas MH, Alba-Cruz R, Rico-Mendez FG: [Bronchial nodules produced by Strongyloides stercoralis as the cause of bronchial obstruction]. Arch Bronconeumol 2003, 39(11):524-526.
• [196]Roman-Velez JM, Martinez-Camacho RN, Alayon-Laguer D, Fernandez-Gonzalez R, Reyes-Sosa R, Santos-Llanos G, Colon-Perez M, Ferrer D: An unusual presentation of alveolar hemorrhage. PCRJ: J Gen Prac Airways Group 2009, 18(4):337-339.
• [197]Arsic-Arsenijevic V, Dzamic A, Dzamic Z, Milobratovic D, Tomic D: Fatal Strongyloides stercoralis infection in a young woman with lupus glomerulonephritis. J Nephrol 2005, 18(6):787-790.
• [198]Finkielman JD, Grinberg AR, Paz LA, Plana JL, Benchetrit GA, Nicastro MA, Roncoroni AJ: Case report: reactive hemophagocytic syndrome associated with disseminated strongyloidiasis. Am J Med Sci 1996, 312(1):37-39.
• [199]Yun HR, Yoo DH, Lee HS, Kim TH, Ahn MH, Min DY, Park MH, Kim SY: Fatal strongyloides hyper-infection in a patient with rheumatoid arthritis. Clin Exp Rheumatol 2001, 19(2):224.
• [200]Koh MS, Leng PH, Eng P, Hwang J: An unusual cause of pulmonary haemorrhage in a patient with rheumatoid arthritis. Ann Acad Med Singap 2004, 33(3):365-367.
• [201]Leung VK, Liew CT, Sung JJ: Fatal strongyloidiasis in a patient with ulcerative colitis after corticosteroid therapy. Am J Gastroenterol 1997, 92(8):1383-1384.
• [202]Shorman M, Al-Tawfiq JA: Strongyloides stercoralis hyperinfection presenting as acute respiratory failure and Gram-negative sepsis in a patient with astrocytoma. IJID: Int Soc Inf Dis 2009, 13(5):e288-e291.
• [203]Fasih N, Irfan S, Sheikh U, Beg MS: A fatal case of gram negative bacterial sepsis associated with disseminated strongyloidiasis in an immunocompromised patient. JPMA 2008, 58(2):91-92.
• [204]Seet RC, Lau LG, Tambyah PA: Strongyloides hyperinfection and hypogammaglobulinemia. Clin Diagn Lab Immunol 2005, 12(5):680-682.
• [205]Czachor JS, Jonas AP: Transmission of Strongyloides steracolis person to person. J Travel Med 2000, 7(4):211-212.
• [206]Csermely L, Jaafar H, Kristensen J, Castella A, Gorka W, Chebli AA, Trab F, Alizadeh H, Hunyady B: Strongyloides hyper-infection causing life-threatening gastrointestinal bleeding. WJG 2006, 12(39):6401-6404.
• [207]Azira NM, Zeehaida M: Strongyloides stercoralis hyperinfection in a diabetic patient: case report. Trop Biomed 2010, 27(1):115-119.
• [208]Vithayasai N, Jennuvat S: Gastrointestinal manifestations in severe strongyloidiasis: report of 3 cases and literature review. Southeast Asian J Trop Med Public Health 2010, 41(1):22-27.
• [209]Pornsuriyasak P, Niticharoenpong K, Sakapibunnan A: Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis. Southeast Asian J Trop Med Public Health 2004, 35(3):531-534.
• [210]Suvajdzic N, Kranjcic-Zec I, Jovanovic V, Popovic D, Colovic M: Fatal strongyloidosis following corticosteroid therapy in a patient with chronic idiopathic thrombocytopenia. Haematologia 1999, 29(4):323-326.
• [211]Hagelskjaer LH: A fatal case of systemic strongyloidiasis and review of the literature. Eur J Clin Microbiol Infect Dis: Eur Soc Clin Microbiol 1994, 13(12):1069-1074.
• [212]Leang B, Lynen L, Tootill R, Griffiths S, Monchy D: Death caused by strongyloides hyperinfection in a leprosy patient on treatment for a type II leprosy reaction. Lepr Rev 2004, 75(4):398-403.
• [213]Wong TY, Szeto CC, Lai FF, Mak CK, Li PK: Nephrotic syndrome in strongyloidiasis: remission after eradication with anthelmintic agents. Nephron 1998, 79(3):333-336.
• [214]Adedayo AO, Grell GA, Bellot P: Case study: Fatal strongyloidiasis associated with human T-cell lymphotropic virus type 1 infection. Am J Trop Med Hyg 2001, 65(5):650-651.
• [215]Foucan L, Genevier I, Lamaury I, Strobel M: [Aseptic purulent meningitis in two patients co-infected by HTLV-1 and Strongyloides stercoralis]. Med Trop (Mars) 1997, 57(3):262-264.
• [216]N’Dri K, Kouame KE, Sahari R, Hommel D, Hulin A: [Strongyloides stercoralis hyperinfection syndrome with acute meningoencephalitis associated to HTLV-1 and HTLV-2 virus co-infection]. Med Mal Infect 2008, 38(3):162-164.
• [217]Drug V, Haliga R, Akbar Q, Mihai C, Cijevschi Prelipcean C, Stanciu C: Ascites with Strongyloides stercoralis in a patient with acute alcoholic pancreatitis and liver cirrhosis. JGLD 2009, 18(3):367-369.
• [218]Ho PL, Luk WK, Chan AC, Yuen KY: Two cases of fatal strongyloidiasis in Hong Kong. Pathology 1997, 29(3):324-326.
• [219]WHO: Model Lists of Essential Medicines. http://www.who.int/medicines/publications/essentialmedicines/en/ webcite